BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 30 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $27,000 | +42.1% | 76,989 | +97.3% | 0.00% | +200.0% |
| Q3 2019 | $19,000 | +111.1% | 39,028 | +158.9% | 0.00% | 0.0% |
| Q2 2019 | $9,000 | -18.2% | 15,072 | -8.6% | 0.00% | 0.0% |
| Q1 2019 | $11,000 | -62.1% | 16,482 | -55.1% | 0.00% | -50.0% |
| Q4 2018 | $29,000 | +16.0% | 36,708 | +60.2% | 0.00% | 0.0% |
| Q3 2018 | $25,000 | -49.0% | 22,909 | +13.3% | 0.00% | 0.0% |
| Q2 2018 | $49,000 | -66.4% | 20,212 | -64.3% | 0.00% | -75.0% |
| Q4 2017 | $146,000 | – | 56,569 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLINSKY STEVEN B | 4,859,885 | $44,614,000 | 20.33% |
| Senator Investment Group LP | 448,679 | $4,119,000 | 0.04% |
| HIGHLAND CAPITAL MANAGEMENT LP | 162,177 | $1,489,000 | 0.03% |
| Baker Brothers Advisors | 350,000 | $3,213,000 | 0.03% |
| Alyeska Investment Group, L.P. | 94,131 | $864,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,000 | $275,000 | 0.01% |
| FMR LLC | 1,302,070 | $11,953,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,427 | $142,000 | 0.00% |
| BlackRock Investment Management, LLC | 846 | $8,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,290 | $159,000 | 0.00% |